Cargando…

Omalizumab for STAT3 Hyper-IgE Syndromes in Adulthood: A Case Report and Literature Review

BACKGROUND: Hyper-immunoglobulin E (IgE) syndromes (HIES) are a group of primary immune deficiencies disorders (PID) characterized by elevated serum IgE, eczema, recurrent skin, or respiratory system infections and may also be accompanied by some connective tissues and skeletal abnormalities. Curren...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lan, Jun, Zhang, Yi, Song, Min, Cai, Shan, Luo, Hong, OuYang, Ruoyun, Yang, Pan, Shi, Xiaoliu, Long, Yingjiao, Chen, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114644/ https://www.ncbi.nlm.nih.gov/pubmed/35602476 http://dx.doi.org/10.3389/fmed.2022.835257

Ejemplares similares

Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome
por: Alonso-Bello, Cesar Daniel, et al.
Publicado: (2019)

Erratum to “Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome”
por: Alonso-Bello, Cesar Daniel, et al.
Publicado: (2021)

Inhibition of IgE and IgE/anti-IgE mediated responses in mast cells by Omalizumab
por: Kulka, M, et al.
Publicado: (2010)

Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange
por: Pennington, Luke F., et al.
Publicado: (2016)

STAT3 Hyper-IgE Syndrome—an Update and Unanswered Questions
por: Tsilifis, Christo, et al.
Publicado: (2021)

Hyper IgE syndrome
por: Dang, Yun, et al.
Publicado: (2014)

Efficacy of Omalizumab Therapy in an Asthmatic with Low IgE
por: R, Divya, et al.
Publicado: (2020)

Omalizumab and IgE in the Control of Severe Allergic Asthma
por: Gon, Yasuhiro, et al.
Publicado: (2022)

Chronic Rhinosinusitis with Nasal Polyps: Targeting IgE with Anti-IgE Omalizumab Therapy
por: Kariyawasam, Harsha H, et al.
Publicado: (2020)

Spontaneous Gastrointestinal Perforations in STAT3-Deficient Hyper-IgE Syndrome
por: Bhattacharya, Sumona, et al.
Publicado: (2020)

Disseminated Talaromyces marneffei Infection With STAT3-Hyper-IgE Syndrome: A Case Series and Literature Review
por: Li, Zhengtu, et al.
Publicado: (2023)

IgG and IgE Autoantibodies to IgE Receptors in Chronic Spontaneous Urticaria and Their Role in the Response to Omalizumab
por: Maronese, Carlo Alberto, et al.
Publicado: (2023)

An update on the hyper-IgE syndromes
por: Yong, Patrick FK, et al.
Publicado: (2012)

Hyper-IgE Syndrome with STAT3 Mutation: A Case Report in Mainland China
por: Xie, Lixin, et al.
Publicado: (2010)

Omalizumab may decrease IgE synthesis by targeting membrane IgE+ human B cells
por: Chan, Marcia A, et al.
Publicado: (2013)

Omalizumab in the management of patients with allergic (IgE-mediated) asthma
por: Sandström, Thomas
Publicado: (2009)

Current and future applications of the anti-IgE antibody omalizumab
por: Incorvaia, Cristoforo, et al.
Publicado: (2008)

Interventional pulmonary procedures and their outcomes in patients with STAT3 hyper IgE syndrome
por: Mahdaviani, Seyed Alireza, et al.
Publicado: (2023)

HYPER IgE SYNDROME WITH UMBILICAL HERNIA
por: Hiremath, N C, et al.
Publicado: (2009)

Clinical Manifestations of Hyper IgE Syndromes
por: Freeman, Alexandra F., et al.
Publicado: (2010)

Autosomal-Recessive Hyper-IgE Syndrome
por: Liza, Mohapatra, et al.
Publicado: (2018)

Pediatric anaphylaxis and hyper IgE syndrome
por: Dosanjh, Amrita
Publicado: (2017)

Staphylococcus aureus and Hyper-IgE Syndrome
por: Park, Bonggoo, et al.
Publicado: (2020)

Hyper-IgE and Carcinoma in CADINS Disease
por: Pietzsch, Leonora, et al.
Publicado: (2022)

Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3
por: Ma, Cindy S., et al.
Publicado: (2008)

A Novel STAT3 Mutation in a Qatari Patient With Hyper-IgE Syndrome
por: Chaimowitz, Natalia S., et al.
Publicado: (2019)

Molecular Assessment of Staphylococcus Aureus Strains in STAT3 Hyper-IgE Syndrome Patients
por: Schwierzeck, Vera, et al.
Publicado: (2022)

Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab
por: Davies, Anna M., et al.
Publicado: (2017)

Specific IgE Response and Omalizumab Responsiveness in Severe Allergic Asthma
por: Tajiri, Tomoko, et al.
Publicado: (2023)

STAT3-Mediated Transcriptional Regulation of Osteopontin in STAT3 Loss-of-Function Related Hyper IgE Syndrome
por: Goel, Shubham, et al.
Publicado: (2018)

Profound differences in IgE and IgG recognition of micro‐arrayed allergens in hyper‐IgE syndromes
por: Garib, Victoria, et al.
Publicado: (2021)

A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma
por: D’Amato, Gennaro, et al.
Publicado: (2007)

Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc complex crystallization
por: Mitropoulou, Alkistis N., et al.
Publicado: (2020)

Relevance of Eosinophilia and Hyper-IgE in Immigrant Children
por: Belhassen-García, Moncef, et al.
Publicado: (2014)

Hyper IgE Syndrome and Renal Cell Carcinoma
por: Patel, Neel H., et al.
Publicado: (2017)

Clinical Profile of Hyper-IgE Syndrome in India
por: Saikia, Biman, et al.
Publicado: (2021)

Hyper IgE Syndrome in an Isolated Population in Israel
por: Lachover-Roth, Idit, et al.
Publicado: (2022)

Hyper IgE syndrome associated with novel and recurrent STAT3 mutations: Two case reports
por: Deng, Ying, et al.
Publicado: (2019)

Retained primary teeth in STAT3 hyper-IgE syndrome: early intervention in childhood is essential
por: Meixner, Iris, et al.
Publicado: (2020)

Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance
por: Asano, Takaki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7c0898irekjn71dui1vdbp3u5d